课题基金 / 基金详情

Central Africa IeDEA

Central Africa IeDEA
中部非洲 IeDEA
批准号:
9132493
负责人:
Kathryn M. Anastos
金额:
$73.7万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-15 至 2016-06-30
关键词:
Acquired Immunodeficiency SyndromeAffectAfricaAfrica South of the SaharaAfricanAfrican AmericanAgeAgingBehavioralCD4 Lymphocyte CountCD4 Positive T LymphocytesCameroonCardiovascular DiseasesCaringCause of DeathCentral AfricaCharacteristicsChronicClinicClinicalClinical DataClinical SciencesCollaborationsComorbidityConflict (Psychology)CountryDataData AnalysesData SetDiseaseDisease ProgressionEffectivenessEnrollmentEnsureEpidemiologyEuropeExposure toFosteringGeneticGovernmentGuidelinesHIVHIV InfectionsHealthImmunologicsIncidenceIndividualIntermediate VariablesInvestigationKidneyKnowledgeLeadershipMalariaMalignant NeoplasmsMetabolicMethodsModelingMonitorMorbidity - disease rateNutritional statusOffice of Administrative ManagementOutcomePatientsPatternPersonsPoliciesPolicy MakerPregnancyPrenatal carePreventionProcessProductivityPublic HealthPublicationsRecording of previous eventsRegimenReproductive HealthResearchResearch InfrastructureResearch SupportResourcesRoleRuralRwandaServicesSourceSpecimenStagingSystemTechnologyTherapeuticTimeToxic effectTuberculosisUrsidae FamilyVertical Disease TransmissionViral Load resultWeight GainWomanWorkantiretroviral therapyburden of illnesscare systemsclinical epidemiologyclinical phenotypedata managementdesignelectronic dataexperienceflexibilityfollow-upimplementation scienceimprovedinnovationinterestmortalityneoplasm registryprogramsreproductiveresponsesexskillssocial stigmasuccesstechnology developmenttranslational studytreatment adherencetreatment program

项目摘要

项目成果

Kathryn M. Anastos的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The promise of antiretroviral therapy (ART) to provide renewed health is now being realized for millions of Africans. As HIV care and treatment programs are implemented throughout Africa, careful monitoring of their effectiveness is of crucial importance, so that care and treatment resources can be deployed to optimal benefit. Immunologic and clinical responses to ART, retention in care, and behavioral components (e.g., treatment adherence) need to be elucidated and predictors of survival defined. The impact of HIV and ART on cancers in Africa is essentially undescribed, and interactions with major ambient co-morbidities such as malaria are poorly understood. We propose a new Central Africa leDEA (CA-leDEA), designed to optimize and augment scientific productivity and rapid, high-impact publications; we will 1.) Compile and manage secondary source patient-level data on a large volume of patients through a.) extraction from existing electronic data, or b.) new on-the-ground systems for efficient capture of clinical data in low-resource clinical settings; 2.) Develop a creative and flexible scientific process that fosters high throughput of many analyses of data to answer epidemiologic, operational and other HIV-related research questions, culminating in high- impact publications; and 3.) Develop capacity for independent research, data management, analysis and publication in each of the Central African countries over five to ten years, ensuring the sustainability of CA-leDEA. Our team brings a long history in the region of research productivity and operational success, as well as innovative IT development to support research, with complementary skills and experience to optimize the activities of CA-leDEA. Four of our partners are the implementers of HIV care services (i.e., the governments) and the fifth partner, WE-ACTx Rwanda, brings patient volume, research experience and special resources to investigate AIDS malignancies. We will develop an administrative and data management infrastructure that supports the implementation of epidemiologic and implementation science to answer key questions in HIV care and treatment in lower-resource settings, with integrated research teams in the US, Cameroon and Rwanda.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Rwanda CASCADE Clinical Trials Site for cervical cancer prevention
  • 批准号:
    10757692
  • 项目类别:
  • 资助金额:
    $22.63万
  • 财政年份:
    2023
  • 负责人:
    Kathryn M. Anastos
  • 依托单位:
Einstein/Rwanda DRC Consortium for Research in HIV/HPV Malignancies
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV/ Malignancies
Einstein/Rwanda/DRC Consortium for Research in HIV/HPV Malignancies
海外基金